Literature DB >> 19624682

Less is more: reducing the reliance on animal models for nausea and vomiting research.

V Robinson1.   

Abstract

Animals have been used as experimental models for centuries and their use has enabled researchers to make significant advances in many areas of human health and disease. However, this is not always the case and there are limitations in using animal models as surrogates for humans, which have hampered the development of efficacious therapeutics for some pathologies. Scientific limitations, together with ethical concerns, legislative changes and the current economic climate are driving researchers to look for and develop alternative non-animal research tools. Technological advances in tissue engineering, 'omics' approaches and in silico modelling for example, are enabling scientists to conduct their research without using animals in a broad range of disciplines, including complex multi-system reflexes such as nausea and vomiting.

Entities:  

Mesh:

Year:  2009        PMID: 19624682      PMCID: PMC2737645          DOI: 10.1111/j.1476-5381.2009.00280.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  Development of an in vitro corrosion/irritation prediction assay using the EpiDerm skin model.

Authors:  D A Kidd; M Johnson; J Clements
Journal:  Toxicol In Vitro       Date:  2007-09-05       Impact factor: 3.500

2.  The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency.

Authors:  Damien Lelièvre; Pascale Justine; François Christiaens; Nicole Bonaventure; Julie Coutet; Laurent Marrot; José Cotovio
Journal:  Toxicol In Vitro       Date:  2007-05-01       Impact factor: 3.500

Review 3.  PDE4 inhibitors: current status.

Authors:  D Spina
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

Review 4.  Opportunities for the replacement of animals in the study of nausea and vomiting.

Authors:  A M Holmes; J A Rudd; F D Tattersall; Q Aziz; P L R Andrews
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

5.  Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Authors:  F Xavier Pi-Sunyer; Louis J Aronne; Hassan M Heshmati; Jeanne Devin; Julio Rosenstock
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

6.  Ondansetron and metformin-induced gastrointestinal side effects.

Authors:  Irene S Hoffmann; Magaly Roa; Fatima Torrico; Luigi X Cubeddu
Journal:  Am J Ther       Date:  2003 Nov-Dec       Impact factor: 2.688

  6 in total
  4 in total

1.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Pioneering better science through the 3Rs: an introduction to the national centre for the replacement, refinement, and reduction of animals in research (NC3Rs).

Authors:  Natalie Burden; Kathryn Chapman; Fiona Sewell; Vicky Robinson
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

Review 3.  Refinement, reduction and replacement approaches to in vivo cardiovascular research.

Authors:  Michael Emerson
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Employment of a noninvasive magnetic method for evaluation of gastrointestinal transit in rats.

Authors:  Caio C Quini; Madileine F Américo; Luciana A Corá; Marcos Ff Calabresi; Matheus Alvarez; Ricardo B Oliveira; Jose Ricardo A Miranda
Journal:  J Biol Eng       Date:  2012-05-15       Impact factor: 4.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.